Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 8/20 | 0.52 |
| ▸ | STING1 | Q86WV6 | 5/20 | 0.46 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.42 |
| ▸ | ITGAV | P06756 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24376372 | 0.92 | BRD4 (0.48) | BRD4STING1PLA2G4AITGB3ITGAV | |
| SCHEMBL31746501 | 0.91 | BRD4 (0.51) | BRD4STING1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL31746582 | 0.91 | STING1 (0.55) | BRD4STING1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL18918040 | 0.87 | BRD4 (0.50) | BRD4STING1ITGB3ITGAV | |
| SCHEMBL18926990 | 0.83 | BRD4 (0.48) | BRD4STING1 | |
| SCHEMBL26910983 | 0.82 | BRD4 (0.47) | BRD4STING1ITGB3ITGAV | |
| SCHEMBL31173833 | 0.79 | BRD4 (0.51) | BRD4STING1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL31169525 | 0.79 | BRD4 (0.51) | BRD4STING1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL31294757 | 0.79 | GLS (0.55) | BRD4STING1 | |
| SCHEMBL29155051 | 0.78 | BRD4 (0.57) | BRD4STING1CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262295-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | DARK BLUE THERAPEUTICS LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| EP-4667466-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | Dark Blue Therapeutics Ltd (GB) | 2025-12-24 | — | — | EP | disclosed |